Practical management of the adverse effects of Hedgehog pathway inhibitor therapy for basal cell carcinoma.
University of Miami Miller School of Medicine, Florida.
Audrey A
AA
Jacobsen
Internal Medicine Residency Program, Florida Atlantic University, Boca Raton, Florida.
Andre R
AR
Kydd
University of Miami Miller School of Medicine, Florida; Internal Medicine Residency Program, Florida Atlantic University, Boca Raton, Florida. Electronic address: strassmail2014@gmail.com.
John
J
Strasswimmer
D000505:Alopecia / Q000139:chemically induced; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D003402:Creatine Kinase / Q000097:blood / Q000187:drug effects; D004408:Dysgeusia / Q000139:chemically induced; D005260:Female; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced; D010049:Ovarian Diseases / Q000139:chemically induced; D011725:Pyridines / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*; D015431:Weight Loss / Q000187:drug effects
D000813:Anilides; D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D053823:Hedgehog Proteins; C538724:HhAntag691; D011725:Pyridines; C561435:sonidegib; D003402:Creatine Kinase